Evidence map›Paper›PMID 43004929›Full record

ReviewGlobal health action2026

Epidemiology of gestational diabetes mellitus in Latin America and the Caribbean: a scoping review.

Adriana Granich-Armenta, Felipe Rangel-Osuna, Alejandra Cantoral, Mónica Ancira Moreno, Christina Anne Vinter, Héctor Lamadrid-Figueroa, Jesper Bo Nielsen, Jens Søndergaard, Fereshteh Baygi

Abstract readScoping ReviewReview
In one paragraph

Review in Global health action, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Adriana Granich-ArmentaResearch Unit of General Practice, Department of Public Health, University of Southern Denmark, Odense, Denmark.ORCID 0000-0001-8889-6937
Felipe Rangel-OsunaHealth Department, Universidad Iberoamericana, Mexico City, Mexico.ORCID 0000-0002-2269-9911
Alejandra CantoralHealth Department, Universidad Iberoamericana, Mexico City, Mexico.ORCID 0000-0002-1397-8476
Mónica Ancira MorenoHealth Department, Universidad Iberoamericana, Mexico City, Mexico.ORCID 0000-0002-9716-7274
Christina Anne VinterResearch Unit of Gynecology and Obstetrics, Odense University Hospital, University of Southern Denmark, Odense, Denmark.ORCID 0000-0001-5084-6053
Héctor Lamadrid-FigueroaDepartment of Perinatal Health, National Institute of Public Health, Cuernavaca, Mexico.ORCID 0000-0001-8775-8399
Jesper Bo NielsenResearch Unit of General Practice, Department of Public Health, University of Southern Denmark, Odense, Denmark.ORCID 0000-0002-5764-5462
Jens SøndergaardResearch Unit of General Practice, Department of Public Health, University of Southern Denmark, Odense, Denmark.ORCID 0000-0002-1629-1864
Fereshteh BaygiResearch Unit of General Practice, Department of Public Health, University of Southern Denmark, Odense, Denmark.ORCID 0000-0002-9260-2281

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gestational diabetes mellitus (GDM) is a major maternal health concern associated with adverse outcomes for mothers and their offspring. In Latin America and the Caribbean (LAC), its burden is heightened by socioeconomic inequalities, limited prenatal care, and high obesity rates, while evidence for other determinants remains fragmented and heterogeneous. This scoping review aimed to identify, describe, and categorize existing research on the prevalence, incidence, determinants, and risk factors of GDM in LAC. We conducted a scoping review following JBI guidance and PRISMA-ScR. Embase, MEDLINE/PubMed, Web of Science, SciELO, and LILACS were searched from inception to December 2025. Eligible studies included observational studies reporting GDM prevalence, incidence, diagnostic criteria, or risk factors in LAC. Two reviewers independently screened records and extracted data. Findings were synthesized descriptively. Fifty‑six studies from nine LAC countries were included, mainly from Brazil and Mexico. Studies were predominantly cross-sectional, cohort, and case-control designs conducted in hospital or prenatal care settings. Diagnostic approaches varied, with IADPSG (39.3%), WHO (25.0%), and ADA (16.1%) as the most frequently used criteria. GDM prevalence ranged from 3.0% to 61.0%, and incidence estimates varied substantially. The most frequently reported determinants and risk factors were advanced maternal age, overweight and obesity, family history of diabetes, previous GDM, prior macrosomia, and hypertension. Behavioral and social determinants were less frequently assessed. Variability in GDM prevalence across LAC highlights the need for standardized regional screening and prospective, population-based research. Reducing the regional GDM burden requires integrating clinical interventions targeting modifiable risk factors and improved continuity of care.

Indexed as

Diabetes, GestationalCaribbean RegionFemaleHumansIncidenceLatin AmericaObesityPregnancyPrevalenceRisk Factorsdiagnostic criteriaGestational diabetes mellitusincidenceprevalencerisk factors

Identifiers

PMID43004929
PMCPMC13757914

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.